Related Experiment Video
Updated: May 6, 2026

The Double-H Maze: A Robust Behavioral Test for Learning and Memory in Rodents
Published on: July 8, 2015
Reversal learning and associative memory impairments in a BACHD rat model for Huntington disease
Yah-Se K Abada1, Huu Phuc Nguyen, Bart Ellenbroek
1Neuropharmacology, EVOTEC AG, Hamburg, Germany ; Brain Research Institute Dept. of Neuropharmacology, University of Bremen - FB 2, Bremen, Germany.
Insights
Huntington disease (HD) rat models show cognitive deficits, including impaired associative memory and reversal learning, before motor symptom onset. These findings support BACHD rats as a valuable model for preclinical Huntington disease drug discovery.
Area of Science:
- Neuroscience
- Genetics
- Animal Models
Background:
- Huntington disease (HD) is a neurodegenerative disorder characterized by chorea and psychiatric symptoms.
- Genetic hallmark of HD is expanded CAG repeats in the Huntingtin (HTT) gene.
- Psychiatric symptoms in HD patients precede motor deficits.
Purpose of the Study:
- To evaluate cognitive performance in BACHD rats, a model for Huntington disease.
- To assess associative memory and reversal learning deficits in BACHD rats.
- To determine the emergence of cognitive symptoms relative to motor deficits in BACHD rats.
Main Methods:
- Cognitive tests including cross-maze for reversal learning and fear conditioning for associative memory were performed on BACHD and wild-type rats.
- BACHD rats carrying the human full-length mutated HTT gene were tested across different age cohorts (2-12 months).
- Pain sensitivity was assessed using a flinch-jump test to rule out confounding factors.
Main Results:
- BACHD rats exhibited impaired reversal learning at 6 months.
- Marked reduction in contextual fear conditioning was observed in BACHD rats from 4 to 12 months.
- Impaired delay and trace fear conditioning were noted at 9 and 3 months, respectively, with no change in pain sensitivity.
Conclusions:
- BACHD rats display significant associative memory deficits and potential reversal learning impairments.
- Cognitive symptoms emerge in BACHD rats prior to motor symptom onset, mirroring human HD progression.
- These findings suggest BACHD rats are a suitable model for preclinical Huntington disease research and drug discovery.
Abstract:
Chorea and psychiatric symptoms are hallmarks of Huntington disease (HD), a neurodegenerative disorder, genetically characterized by the presence of expanded CAG repeats (>35) in the Huntingtin (HTT) gene. HD patients present psychiatric symptoms prior to the onset of motor symptoms and we recently found a similar emergence of non motor and motor deficits in BACHD rats carrying the human full length mutated HTT (97 CAG-CAA repeats). We evaluated cognitive performance in reversal learning and associative memory tests in different age cohorts of BACHD rats. Male wild type (WT) and transgenic (TG) rats between 2 and 12 months of age were tested. Learning and strategy shifting were assessed in a cross-maze test. Associative memory was evaluated in different fear conditioning paradigms (context, delay and trace). The possible confound of a fear conditioning phenotype by altered sensitivity to a 'painful' stimulus was assessed in a flinch-jump test. In the cross maze, 6 months old TG rats showed a mild impairment in reversal learning. In the fear conditioning tasks, 4, 6 and 12 months old TG rats showed a marked reduction in contextual fear conditioning. In addition, TG rats showed impaired delay conditioning (9 months) and trace fear conditioning (3 months). This phenotype was unlikely to be affected by a change in 'pain' sensitivity as WT and TG rats showed no difference in their threshold response in the flinch-jump test. Our results suggest that BACHD rats have a profound associative memory deficit and, possibly, a deficit in reversal learning as assessed in a cross maze task. The time course for the emergence of these symptoms (i.e., before the occurrence of motor symptoms) in this rat model for HD appears similar to the time course in patients. These data suggest that BACHD rats may be a useful model for preclinical drug discovery.
More Related Videos
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018